Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (271-280 of 578) with videos related to

Pageof 58
Sort By:
Gynecologic Oncology|July 23, 2025
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancerUrsula A Matulonis, Ignace Vergote, Kathleen N Moore, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2019
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumorsAn Coosemans, Thaïs Baert, Jolien Ceusters, et al.
Cancer Research Communications|December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical TrialsHailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Gynecologic Oncology|August 2, 2015
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapiesJeroen Depreeuw, Els Hermans, Stefanie Schrauwen, et al.
Frontiers in Pharmacology|August 23, 2018
Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian CancerMartin Svoboda, Felicitas Mungenast, Andreas Gleiss, et al.
European Radiology|June 27, 2018
Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre studyMaarten G Thomeer, Vincent Vandecaveye, Loes Braun, et al.
Anticancer Research|March 16, 2016
Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European ConsortiumIrena Rohr, Robert Zeillinger, Michaela Heinrich, et al.
Lymphatic Research and Biology|August 22, 2014
Reproducibility of lymphoscintigraphic evaluation of the upper limbNele Devoogdt, Tim Van den Wyngaert, Pierre Bourgeois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 30, 2013
Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCADRadoslav Chekerov, Ioana Braicu, Dan Cacsire Castillo-Tong, et al.
Gynecologic Oncology|September 3, 2013
Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapyElfriede Greimel, Gunnar B Kristensen, Maria E L van der Burg, et al.
Pageof 58

Showing results (271-280 of 578) with videos related to

Sort By:
Pageof 58
Gynecologic Oncology|July 23, 2025
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancerUrsula A Matulonis, Ignace Vergote, Kathleen N Moore, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2019
Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumorsAn Coosemans, Thaïs Baert, Jolien Ceusters, et al.
Cancer Research Communications|December 5, 2024
Potential Synergistic Effect between Niraparib and Statins in Ovarian Cancer Clinical TrialsHailei Zhang, Anna Rutkowska, Antonio González-Martín, et al.
Gynecologic Oncology|August 2, 2015
Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapiesJeroen Depreeuw, Els Hermans, Stefanie Schrauwen, et al.
Frontiers in Pharmacology|August 23, 2018
Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian CancerMartin Svoboda, Felicitas Mungenast, Andreas Gleiss, et al.
European Radiology|June 27, 2018
Evaluation of T2-W MR imaging and diffusion-weighted imaging for the early post-treatment local response assessment of patients treated conservatively for cervical cancer: a multicentre studyMaarten G Thomeer, Vincent Vandecaveye, Loes Braun, et al.
Anticancer Research|March 16, 2016
Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European ConsortiumIrena Rohr, Robert Zeillinger, Michaela Heinrich, et al.
Lymphatic Research and Biology|August 22, 2014
Reproducibility of lymphoscintigraphic evaluation of the upper limbNele Devoogdt, Tim Van den Wyngaert, Pierre Bourgeois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 30, 2013
Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCADRadoslav Chekerov, Ioana Braicu, Dan Cacsire Castillo-Tong, et al.
Gynecologic Oncology|September 3, 2013
Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapyElfriede Greimel, Gunnar B Kristensen, Maria E L van der Burg, et al.
Pageof 58